TNF and skin squamous cell carcinoma: However, many register-based cohort studies and systematic reviews of randomized trials had not identified such an increased risk of overall cancer with the use of anti-TNFα, with the exception of an increased risk of squamous cell skin cancer risk in patients treated with abatacept (Xie et al., 2020; Chen et al., 2021; Li et al., 2021).